Splenda and sucralose proven to contribute to development of diabetes
(NaturalNews) One of the world's most popular non-caloric sweeteners has recently been exposed as a complete fraud. A new study published in the journal Diabetes Care reveals that Splenda (sucralose), which is commonly marketed to diabetics as a safe, non-nutritive sweetener (NNS), actually elicits a diabetes-promoting effect in people who consume it.
Researchers from the Center for Human Nutrition at the Washington University School of Medicine in St. Louis, Missouri, made this discovery after evaluating the metabolic effects of consuming Splenda on a small group of 17 human participants, all of whom were obese and who did not consume artificial sweeteners at the beginning of the study. Each participant was subjected to either Splenda or control water 10 minutes prior to undergoing a five-hour glucose tolerance test.
At the conclusion of the randomized crossover trial, the team observed that Splenda consumption prompted noticeable changes in terms of insulin production, circulating insulin levels, and bodily sensitivity to insulin. As relayed by GreenMedInfo.com, a single dose of Splenda was found to increase plasma glucose concentrations by 0.6 nanomoles per liter (nmol/L). It also led to a 20 percent spike in insulin levels, a 22 percent increased peak insulin secretion rate, a 7 percent decrease in insulin clearance, and a 23 percent decrease in insulin sensitivity.
"Compared with the control condition, sucralose ingestion caused 1) a greater incremental increase in peak plasma glucose concentrations, 2) a ... greater incremental increase in insulin area under the curve Continue reading